Drugs / ADPS
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02935036 | Oct 2016 → Jan 2017 | acne | Sun Pharmaceutical Industries, Inc. | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ADPS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02935036 ↗ |
| Route | Topical | “A thin layer of study medication will be applied to cover affected areas once daily for 12 weeks” NCT02935036 ↗ |